Insights On Enterprise Solutions

  1. Evaluating Mixing Performance Across Liquids, Solids, And Powders 8/20/2026

    Analytical readings may indicate uniformity before mixing appears visually complete. Explore how material behavior, agitation, working volume, and addition methods affect mixing times.

  2. Reliable Mixing Across Changing Batch Volumes 8/20/2026

    See how working volume and agitation speed influence mixing, with practical performance data to help teams assess efficiency across a broad range of upstream and downstream operating conditions.

  3. Quality With Purpose: From Manufacturing Excellence To Patient Impact 8/19/2026

    When quality and purpose align, pharmaceutical teams can overcome challenges, accelerate innovation, and bring safe, effective therapies to patients worldwide.

  4. New Promises, New Pressures, No Problem - Service Care Packages 8/19/2026

    Tighter production schedules leave little room for equipment disruption. Get support that can strengthen maintenance strategies, reduce operational risk, and help internal teams sustain performance.

  5. Lyophilization Process Development For Antibody Drug Conjugates 8/18/2026

    See how scientific process development and QbD principles improve freeze-drying performance, strengthen product stability, and support biologics scale-up.

  6. Lonza Capabilities Update August 2026: Cell Line Development 8/18/2026

    Omeco Barrett, Principal Scientist, Global Process Development, highlights Lonza’s latest development in cell line expression technology and cell line development (CLD).

  7. Why Upstream-Downstream Alignment Determines Success In Complex Biologics 8/18/2026

    Aligning early upstream choices, downstream purification, and analytical testing prevents scale-up delays, reduces process variability, and protects timelines for complex biologics.

  8. Exploring 4 Patient-Centric Trends Shaping Today's Biopharma Landscape 8/17/2026

    Patient centricity is reshaping pharma drug development through supply chain resiliency, decentralized trials, and patient-friendly formulations. Learn what these shifts mean for your pipeline strategy.

  9. Systemic Modularity: A Roadmap To Flexible, Efficient Biopharmaceutical Manufacturing 8/13/2026

    Modernizing biomanufacturing requires shifting from rigid, custom setups toward modular automation, data-rich sensors, and plug-and-produce operations. 

  10. When Unexpected Particles Threaten Your Biologic 8/13/2026

    Particle contamination risks biologic safety. Advanced tools like Raman and SEM-EDS identify root causes fast to support robust, regulator-ready strategies that protect product quality.